Selected article for: "Co pathogen infection and present study"

Author: Piewbang, Chutchai; Rungsipipat, Anudep; Poovorawan, Yong; Techangamsuwan, Somporn
Title: Cross-sectional investigation and risk factor analysis of community-acquired and hospital-associated canine viral infectious respiratory disease complex
  • Document date: 2019_11_14
  • ID: r5oefcrj_28
    Snippet: In the present study, 81.2% (108/133) of CAI and 78.9% (60/76) of HAI dogs had multiple CIRDV infections, supporting the complex condition of the disease, which is often manifested as a co-infection rather than a single pathogen [2, 3, 24, 26, 38] . We also observed that the majority of multiple CIRDV infections were co-detected with either CIV, CRCoV, or both. However, this observation does not allow interpretation as to whether they are primary.....
    Document: In the present study, 81.2% (108/133) of CAI and 78.9% (60/76) of HAI dogs had multiple CIRDV infections, supporting the complex condition of the disease, which is often manifested as a co-infection rather than a single pathogen [2, 3, 24, 26, 38] . We also observed that the majority of multiple CIRDV infections were co-detected with either CIV, CRCoV, or both. However, this observation does not allow interpretation as to whether they are primary and/or secondary pathogens. Infection with CIV and CRCoV usually induces mild clinical symptoms by interfering with the respiratory defense mechanism and so leads to super-infections with other pathogens [1, 41, 42] . Moreover, co-infection of CIV and CRCoV may be synergistic and lead to severe tracheobronchitis [41] .

    Search related documents:
    Co phrase search for related documents
    • clinical symptom and mild clinical symptom: 1, 2, 3, 4, 5, 6, 7, 8
    • clinical symptom and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • complex condition and present study: 1, 2
    • defense mechanism and present study: 1, 2, 3, 4, 5
    • defense mechanism and respiratory defense mechanism: 1, 2, 3, 4, 5
    • present study and single pathogen: 1, 2, 3, 4, 5, 6, 7
    • primary secondary pathogen and secondary pathogen: 1, 2, 3, 4, 5, 6